Omnicell
OMCL
249 hedge funds and large institutions have $1.38B invested in Omnicell in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 101 increasing their positions, 80 reducing their positions, and 52 closing their positions.
103,950% more call options, than puts
Call options by funds: $2.08M | Put options by funds: $2K
26% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 80
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.2% less ownership
Funds ownership: 100.21% → 100.02% (-0.2%)
10% less capital inflows, than outflows
Capital inflows: $184M | Capital outflows: $204M
9% less funds holding
Funds holding: 274 → 249 (-25)
44% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cadian Capital Management
New York
|
+$49.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$19.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$9.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Champlain Investment Partners
Burlington,
Vermont
|
-$50.7M |
| 2 |
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$25M |
| 3 |
Millennium Management
New York
|
-$13.7M |
| 4 |
Oberweis Asset Management
Lisle,
Illinois
|
-$11.6M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$9.32M |
OMCL Hedge Fund Activity: Q2 2025 in Review
249 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q2 2025, worth a combined $1.38B — down 16% from $1.64B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of OMCL and 29 opened new positions — a net loss of 23 holders — while 80 trimmed existing stakes and 101 added.
The largest buyer was Cadian Capital Management, opening a new position worth an estimated $49.7M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $50.7M sold.
- 249 institutional investors held Omnicell (OMCL) as of Q2 2025, down from 274 in Q1 2025.
- Funds reported $1.38B of Omnicell stock for Q2 2025, down 16% quarter-over-quarter.
- 29 funds opened new Omnicell positions in Q2 2025 and 52 closed out, a net change of -23 holders.
- The largest Omnicell buyer in Q2 2025 was Cadian Capital Management, an estimated $49.7M added.
- The largest Omnicell seller in Q2 2025 was Champlain Investment Partners, an estimated $50.7M sold.
Based on aggregated 13F filings for Q2 2025.